Nature. 1990 Jun 21;345(6277):724-6.

Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.

Slattery RM, Kjer-Nielsen L, Allison J, Charlton B, Mandel TE, Miller JF.

Source

Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.

Abstract

The non-obese diabetic (NOD) mouse develops insulin-dependent diabetes mellitus (IDDM) with mononuclear cell infiltration of the islets of Langerhans and selective destruction of the insulin-producing beta-cells, as in humans. Most infiltrating cells are T lymphocytes, and most of these carry the CD4 antigen. Adoptive transfer of T cells from diabetic NOD mice into irradiated NOD or athymic nude NOD mice induces diabetes. Susceptibility to IDDM in NOD mice is polygenic, with one gene linked to the major histocompatibility complex class II locus, which in NOD mice expresses a unique I-A molecule but no I-E. Speculation exists as to the role of the I-A molecule in the diabetes susceptibility of NOD mice, especially regarding the significance of specific unique residues. To examine the role of the NOD I-A molecule in IDDM pathogenesis, we made NOD/Lt mice transgenic for I-Ak by microinjecting I-Ak alpha- and beta-genes into fertilized NOD/Lt eggs. Insulitis was markedly reduced and diabetes prevented in NOD/Lt mice expressing I-Ak.

Comment in

Nature. 1990 Jun 21;345(6277):662-4.

PMID:: 1972779; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Diabetes Type 1 - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. [Nature. 1990]
Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
Lund T, O'Reilly L, Hutchings P, Kanagawa O, Simpson E, Gravely R, Chandler P, Dyson J, Picard JK, Edwards A. Nature. 1990 Jun 21; 345(6277):727-9.
Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. [Nature. 1987]
Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Nature. 1987 Jul 30-Aug 5; 328(6129):432-4.
Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse. [Clin Exp Immunol. 1996]
Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse.
Yamane K, Yamamoto K, Yoshikawa Y, Sasazuki T. Clin Exp Immunol. 1996 Jan; 103(1):141-8.
Review Genetic and immunological basis of autoimmune diabetes in the NOD mouse. [Rev Immunogenet. 2000]
Review Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K, Kikutani H. Rev Immunogenet. 2000; 2(1):140-6.
Review Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice. [Immunol Rev. 1999]
Review Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice.
Suri A, Katz JD. Immunol Rev. 1999 Jun; 169:55-65.

See reviews... See all...

Cited by 32 PubMed Central articles

Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy. [Diabetes. 2011]
Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.
Bertin-Maghit S, Pang D, O'Sullivan B, Best S, Duggan E, Paul S, Thomas H, Kay TW, Harrison LC, Steptoe R, et al. Diabetes. 2011 Jan; 60(1):248-57. Epub 2010 Oct 27.
Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. [Int Immunol. 2010]
Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect.
Brims DR, Qian J, Jarchum I, Mikesh L, Palmieri E, Ramagopal UA, Malashkevich VN, Chaparro RJ, Lund T, Hattori M, et al. Int Immunol. 2010 Mar; 22(3):191-203. Epub 2010 Jan 21.
Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1. [J Immunol. 2008]
Effector mechanisms of the autoimmune syndrome in the murine model of autoimmune polyglandular syndrome type 1.
Devoss JJ, Shum AK, Johannes KP, Lu W, Krawisz AK, Wang P, Yang T, Leclair NP, Austin C, Strauss EC, et al. J Immunol. 2008 Sep 15; 181(6):4072-9.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
Nature. 1990 Jun 21 ;345(6277):724-6.

PubMed
The Landing Error Scoring System (LESS) Is a valid and reliable clinical assessm...
The Landing Error Scoring System (LESS) Is a valid and reliable clinical assessment tool of jump-landing biomechanics: The JUMP-ACL study.
Am J Sports Med. 2009 Oct ;37(10):1996-2002. Epub 2009 Sep 2 .

PubMed
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma pro...
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.
Lancet. 1990 Jun 30 ;335(8705):1544-7.

PubMed
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnor...
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
J Rheumatol. 2009 Oct ;36(10):2250-6. Epub 2009 Sep 1 .

PubMed
Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabet...
Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.
J Exp Med. 1990 Jun 1 ;171(6):2077-89.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.

Source

Abstract

Comment in

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 32 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information